← Evidence map

ReviewInternational ophthalmology2025

Secretogranin III: a promising therapeutic target for intraocular neovascular lesions.

Chao-Yi Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39832055